๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements

โœ Scribed by Philip D. Harvey; Michael F. Green; Christopher Bowie; Antony Loebel

Publisher
Springer
Year
2006
Tongue
English
Weight
162 KB
Volume
187
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The olfactory and cognitive deficits of
The olfactory and cognitive deficits of parkinson's disease: Evidence for independence
โœ Richard L. Doty; Manuel Riklan; Daniel A. Deems; Constance Reynolds; Stanley Ste ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 656 KB

In the present study we sought to determine whether the olfactory deficits of parkinsonism are related to the cognitive and perceptual-motor manifestations of the disease. Pearson correlation coefficients were computed among a number of olfactory, neurologicai, and neuropsychological measures obtain

French recommendations for clinical drug
French recommendations for clinical drug trials in cognitive disorders of the elderly
โœ Dr. Bernard Michel; Roland Sambuc; Jean-Claude Scotto ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 449 KB ๐Ÿ‘ 2 views

## Abstract A consensus conference on the topic of clinical drug trials in cognitive disorders of the elderly was held in Marseille on January 28โ€“29, 1993. At the end of this conference, several recommendations were made. Drugs used in trials must be chosen according to solid neurobiological eviden

A method for determining the magnitude o
A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam
โœ Peter J. Snyder; John Werth; Bruno Giordani; Angela F. Caveney; Douglas Feltner; ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 107 KB

## Abstract While there is no doubt that benzodiazepine administration leads to transient cognitive impairment in healthy adults, the nature and magnitude of such impairment has not been well described. The cognitive effects of a single dose of alprazolam 0.5 and 1โ€‰mg were therefore assessed in 36